Literature DB >> 33528964

Patient-specific prediction model for clinical and quality-of-life outcomes after lumbar spine surgery.

Daniel Lubelski1, James Feghali1, Amy S Nowacki2,3, Vincent J Alentado4, Ryan Planchard1, Kalil G Abdullah5, Daniel M Sciubba1, Michael P Steinmetz2,6, Edward C Benzel2,6, Thomas E Mroz2,6.   

Abstract

OBJECTIVE: Patient demographics, comorbidities, and baseline quality of life (QOL) are major contributors to postoperative outcomes. The frequency and cost of lumbar spine surgery has been increasing, with controversy revolving around optimal management strategies and outcome predictors. The goal of this study was to generate predictive nomograms and a clinical calculator for postoperative clinical and QOL outcomes following lumbar spine surgery for degenerative disease.
METHODS: Patients undergoing lumbar spine surgery for degenerative disease at a single tertiary care institution between June 2009 and December 2012 were retrospectively reviewed. Nomograms and an online calculator were modeled based on patient demographics, comorbidities, presenting symptoms and duration of symptoms, indication for surgery, type and levels of surgery, and baseline preoperative QOL scores. Outcomes included postoperative emergency department (ED) visit or readmission within 30 days, reoperation within 90 days, and 1-year changes in the EuroQOL-5D (EQ-5D) score. Bootstrapping was used for internal validation.
RESULTS: A total of 2996 lumbar surgeries were identified. Thirty-day ED visits were seen in 7%, 30-day readmission in 12%, 90-day reoperation in 3%, and improvement in EQ-5D at 1 year that exceeded the minimum clinically important difference in 56%. Concordance indices for the models predicting ED visits, readmission, reoperation, and dichotomous 1-year improvement in EQ-5D were 0.63, 0.66, 0.73, and 0.84, respectively. Important predictors of clinical outcomes included age, body mass index, Charlson Comorbidity Index, indication for surgery, preoperative duration of symptoms, and the type (and number of levels) of surgery. A web-based calculator was created, which can be accessed here: https://riskcalc.org/PatientsEligibleForLumbarSpineSurgery/.
CONCLUSIONS: The prediction tools derived from this study constitute important adjuncts to clinical decision-making that can offer patients undergoing lumbar spine surgery realistic and personalized expectations of postoperative outcome. They may also aid physicians in surgical planning, referrals, and counseling to ultimately lead to improved patient experience and outcomes.

Entities:  

Keywords:  calculator; lumbar; nomogram; outcome; prediction; quality of life; spine surgery

Mesh:

Year:  2021        PMID: 33528964     DOI: 10.3171/2020.8.SPINE20577

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  4 in total

1.  Do preoperative clinical and radiographic characteristics impact patient outcomes following one-level minimally invasive transforaminal lumbar interbody fusion based upon presenting symptoms?

Authors:  Kyle W Morse; Ram K Alluri; Avani S Vaishnav; Hikari Urakawa; Jung Kee Mok; Sohrab S Virk; Evan D Sheha; Sheeraz A Qureshi
Journal:  Spine J       Date:  2021-10-23       Impact factor: 4.297

2.  The risk factors and predictive nomogram of human albumin infusion during the perioperative period of posterior lumbar interbody fusion: a study based on 2015-2020 data from a local hospital.

Authors:  Bo Liu; Junpeng Pan; Hui Zong; Zhijie Wang
Journal:  J Orthop Surg Res       Date:  2021-10-30       Impact factor: 2.359

3.  Parecoxib Reduced Postsurgical Pain and Facilitated Movement More Than Patient Controlled Analgesia.

Authors:  Szu-Ching Chiu; Hanoch Livneh; Jin-Cheng Chen; Chia-Ming Chang; Honda Hsu; Tsay-I Chiang; Tzung-Yi Tsai
Journal:  Front Surg       Date:  2022-04-06

4.  The Charlson Comorbidity Index and depression are associated with satisfaction after short-segment lumbar fusion in patients 75 years and older.

Authors:  Shuai-Kang Wang; Hong Mu; Peng Wang; Xiang-Yu Li; Chao Kong; Jing-Bo Cheng; Shi-Bao Lu; Guo-Guang Zhao
Journal:  Front Surg       Date:  2022-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.